![James Murphy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Murphy
Keine laufenden Positionen mehr
Profil
James B. Murphy worked as Controller at Sumitomo Pharma America, Inc. from 1990 to 1994.
From 1994 to 2001, served as Chief Financial Officer & Senior VP-Administration at HMSR, Inc. Held the position of Vice President-Finance at Whatman, Inc. between 2001 and 2003.
Worked at Oncotelic Therapeutics, Inc. from 2004 to 2012, including Vice President & Chief Financial Officer in 2011.
Served as Chief Financial Officer, Secretary & Treasurer at Morphic Medical, Inc. from 2016 to 2017.
Held the role of Chief Financial & Accounting Officer at Decibel Therapeutics, Inc. from 2022 to 2023.
Worked as Chief Financial Officer at Helix BioPharma Corp.
from 2024 to 2025.
Served as Chief Financial & Accounting Officer at Mustang Bio, Inc. in 2024.
Attended College of the Holy Cross (Massachusetts) for undergraduate studies.
Ehemalige bekannte Positionen von James Murphy
| Unternehmen | Position | Ende |
|---|---|---|
| HELIX BIOPHARMA CORP. | Finanzdirektor/CFO | 02.06.2025 |
| DECIBEL THERAPEUTICS, INC. | Finanzdirektor/CFO | 22.09.2023 |
| GI DYNAMICS, INC. | Finanzdirektor/CFO | 01.12.2017 |
| ONCOTELIC THERAPEUTICS, INC. | Finanzdirektor/CFO | 31.03.2012 |
Whatman, Inc.
 Whatman, Inc. Industrial MachineryProducer Manufacturing Develops, manufactures, and markets separation technology devices | Finanzdirektor/CFO | 01.05.2003 |
Ausbildung von James Murphy
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
56
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Health Technology |
Oncotelic Therapeutics, Inc.
 Oncotelic Therapeutics, Inc. BiotechnologyHealth Technology Engages in developing novel small-molecule therapeutics to treat cancer and eye diseases | Health Technology |
Helix BioPharma Corp.
 Helix BioPharma Corp. Pharmaceuticals: MajorHealth Technology Develops drugs for the prevention and treatment of cancer | Health Technology |
MORPHIC MEDICAL INC
 MORPHIC MEDICAL INC Medical SpecialtiesHealth Technology Designs, develops, and markets medical devices for the treatment of diabetes and obesity, and their complexities | Health Technology |
College of the Holy Cross (Massachusetts)
 College of the Holy Cross (Massachusetts) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
HMSR, Inc.
 HMSR, Inc. Medical SpecialtiesHealth Technology Develops products for blood transfusion and collection procedures | Health Technology |
Whatman, Inc.
Whatman, Inc. Industrial MachineryProducer Manufacturing Develops, manufactures, and markets separation technology devices | Producer Manufacturing |
Decibel Therapeutics, Inc.
 Decibel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops medicines for hearing and balance disorders | Health Technology |
Mustang Bio, Inc.
 Mustang Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops novel immunotherapy''s | Health Technology |
